← Back to Clinical Trials
Recruiting NCT03925311
Transcriptome Profiling and Endometrial Receptivity
◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
Condition Pregnancy Related
Sponsor Chinese University of Hong Kong
Study Type OBSERVATIONAL
Phase N/A
Enrollment 220
Sex FEMALE
Min Age 20 Years
Max Age 40 Years
Start Date 2015-04-20
Completion 2025-12-31
Interventions
endometrial biopsy and blood sampling
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The aim of this study is to correlate and identify the biochemical markers which may reflect WOI. Blood samples will be collected and endometrial biopsy will be performed at particular time points.
Eligibility Criteria
Inclusion Criteria: Age 20-40 years. Exclusion Criteria: * Uncorrected uterine anomalies, such as septate or bicornuate uterus, fibroids (submucous/intramural). * Intrauterine adhesions. * Adenomyosis.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology